Phase II trial of second line therapy with Oxaliplatin and Pemetrexed in patients with advanced pancreatic cancer.
Phase of Trial: Phase II
Latest Information Update: 26 May 2011
At a glance
- Drugs Oxaliplatin (Primary) ; Pemetrexed (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 26 May 2011 New trial record